Continuous Low Intensity Ultrasound Improves Cartilage Repair in Rabbit Model of Subchondral Injury

Anuradha Subramanian,Sarayu Bhogoju,Oraine Snaith,April Miller,Heather Newell,Denzhi Wang,Gene Siegal,Katelin Oborny,Jesse Baumann-Berg,Hendrik Viljoen

DOI: https://doi.org/10.1089/ten.tea.2023.0246

IF: 4.08

2024-02-07

Tissue Engineering Part A

Abstract:Subchondral drilling (SD), a bone marrow stimulation technique, is used to repair cartilage lesions that lack regenerative potential. Cartilage repair outcomes upon SD are typically fibrocartilaginous in nature with inferior functionality. The lack of cues to foster the chondrogenic differentiation of egressed mesenchymal stromal cells (MSCs) upon SD, can be attributed for the poor outcomes. Continuous low-intensity ultrasound (cLIUS) at 3.8 MHz is proposed as a treatment modality for improving cartilage repair outcomes upon marrow stimulation. Bilateral defects were created via SD on the femoral medial condyle of female New Zealand white rabbits (n=12) and the left joint received cLIUS treatment (3.8 MHz, 3.5 Vpp, 8 minutes/application/day) and the contralateral right joint served as the control. On day-7 post surgery, synovial fluid was aspirated and the cytokine levels were assessed by QuantibodyTM assay. Rabbits were euthanized at 8-weeks and outcomes were assessed macroscopically and histologically. Defect areas in the right joints exhibited boundaries, incomplete fill, irregular cartilage surfaces, loss of glycosaminoglycan (GAG), and absence of chondrocytes. In contrast, the repaired defect area in the joints that received cLIUS showed complete fill, positive staining for GAG with rounded chondrocyte morphology, COL2A1 staining and columnar organization. Synovial fluid collected from cLIUS treated left knee joints had lower levels of IL1, TNFα and IFNγ when compared to untreated right knee joints, alluding to the potential of cLIUS to mitigate early inflammation. Further at 8-weeks, left knee joints (n=12) consistently scored higher on the O"Driscoll scale; with a higher % hyaline cartilage score. No adverse impact on bone or change in the joint space was noted. Upon a single exposure of cLIUS to TNFα treated cells, nuclear localization of pNFκB and SOX9 was visualized by double immunofluorescence and the expression of markers associated with the NFκB pathway was assayed by qRT-PCR. cLIUS extends its chondroprotective effects by titrating pNFκB levels, preventing its nuclear translocation while maintaining the expression of SOX9, the collagen II transcription factor. Our combined results demonstrate that healing of chondral defects treated with marrow stimulation via SD can be accelerated by employing cLIUS regimen that possess chondroinductive and chondroprotective properties.

cell biology,cell & tissue engineering,engineering, biomedical,materials science, biomaterials